Is Charles River Laboratories Stock Underperforming the Dow? [Yahoo! Finance]
Charles River Laboratories International, Inc. (CRL)
Last charles river laboratories international, inc. earnings: 2/11 07:00 am
Check Earnings Report
US:NYSE Investor Relations:
ir.criver.com
Company Research
Source: Yahoo! Finance
the pharmaceutical, biotechnology, government and academic sectors. The Wilmington, Massachusetts-based company provides preclinical and early-stage drug discovery, safety assessment, and laboratory services that support the development of new drugs, vaccines and medical devices. Companies worth between $2 billion and $10 billion are generally described as "mid-cap stocks." CRL fits right into that category. It benefits from a strong competitive position driven by its end-to-end preclinical drug development capabilities, market leadership in research models, and deep, long-standing relationships with pharmaceutical and biotech clients. Its global scale, regulatory expertise, and specialized scientific infrastructure create high barriers to entry and significant switching costs, supporting recurring revenues and customer retention. Broadcom Stock Dips Post Earnings: Is AVGO a Buy, Sell, or Hold? The QQQ Is at Risk of a Christmas Crash, So Pay Attention to Bond Yields Right Now
Show less
Read more
Impact Snapshot
Event Time:
CRL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CRL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CRL alerts
High impacting Charles River Laboratories International, Inc. news events
Weekly update
A roundup of the hottest topics
CRL
News
- Charles River Laboratories International (NYSE:CRL) had its price target raised by analysts at JPMorgan Chase & Co. from $165.00 to $190.00. They now have a "neutral" rating on the stock.MarketBeat
- Charles River Laboratories International (NYSE:CRL) was upgraded by analysts at Bank of America Corporation from a "neutral" rating to a "buy" rating. They now have a $225.00 price target on the stock.MarketBeat
- Charles River Laboratories International (NYSE:CRL) had its "overweight" rating reaffirmed by analysts at Barclays PLC.MarketBeat
- Charles River Extends Commitment to Advanced Therapy Developers with Second Incubator Program Cohort [Yahoo! Finance]Yahoo! Finance
- Charles River Extends Commitment to Advanced Therapy Developers with Second Incubator Program CohortBusiness Wire
CRL
Earnings
- 11/5/25 - Beat
CRL
Sec Filings
- 12/3/25 - Form 8-K
- 11/17/25 - Form 8-K
- 11/14/25 - Form SCHEDULE
- CRL's page on the SEC website